The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models

Diabetes

Volumn 60, Issue 9, 2011, Pages 2370-2378

  Opreanu, Madalina ^a,b   Tikhonenko, Maria ^a   Bozack, Svetlana ^a,b   Lydic, Todd A ^a,b   Reid, Gavin E ^a   McSorley, Kelly M ^a   Sochacki, Andrew ^a   Perez, Gloria I ^a   Esselman, Walter J ^b   Kern, Timothy ^c   Kolesnick, Richard ^d   Grant, Maria B ^e   Busik, Julia V ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Case Western Reserve University ^*  (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CERAMIDE; DOCOSAHEXAENOIC ACID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GLIA CELL; HUMAN; HUMAN CELL; LIPID COMPOSITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ANIMALS; CAPILLARIES; CAPILLARY PERMEABILITY; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RETINAL VESSELS; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 80052899912     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0550     Document Type: Article

References (50)

1. Imai H, Singh RS, Fort PE, Gardner TW. Neuroprotection for diabetic retinopathy. Dev Ophthalmol 2009;44:56-68
2. Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 2008;30:65-84
3. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007;2007:95103.
4. Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 2002;16:438-440
5. Yang LP, Sun HL, Wu LM, et al. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest Ophthalmol Vis Sci 2009;50:2319-2327
6. Nozaki M, Ogura Y, Hirabayashi Y, Saishin Y, Shimada S. Enhanced expression of adhesion molecules of the retinal vascular endothelium in spontaneous diabetic rats. Ophthalmic Res 2002;34:158-164 (Pubitemid 34827817)
7. Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999;96:10836-10841 (Pubitemid 29442230)
8. Simonaro CM, Park JH, Eliyahu E, Shtraizent N, McGovern MM, Schuchman EH. Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann-Pick disease. Am J Hum Genet 2006;78:865-870
9. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial - Diabetic Retinopathy Vitrectomy Study Report 4. Ophthalmology 1988;95:1321-1334
10. Marchesini N, Hannun YA. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 2004;82:27-44 (Pubitemid 38580872)
11. Liu P, Anderson RG. Compartmentalized production of ceramide at the cell surface. J Biol Chem 1995;270:27179-27185
12. Ko YG, Lee JS, Kang YS, Ahn JH, Seo JS. TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. J Immunol 1999;162:7217-7223
13. Martin MU, Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 2002;1592:265-280 (Pubitemid 35284883)
14. Andrieu-Abadie N, Levade T. Sphingomyelin hydrolysis during apoptosis. Biochim Biophys Acta 2002;1585:126-134 (Pubitemid 36092076)
15. Marathe S, Schissel SL, Yellin MJ, et al. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem 1998;273:4081-4088 (Pubitemid 28103275)
16. Opreanu M, Lydic TA, Reid GE, McSorley KM, Esselman WJ, Busik JV. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid. Invest Ophthalmol Vis Sci 2010;51:3253-3263
17. Connor KM, SanGiovanni JP, Lofqvist C, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007;13:868-873 (Pubitemid 47038185)
18. Tikhonenko M, Lydic TA, Wang Y, et al. Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes 2010;59:219-227
19. Futterman S, Kupfer C. The fatty acid composition of the retinal vasculature of normal and diabetic human eyes. Invest Ophthalmol 1968;7:105-108
20. Chen W, Esselman WJ, Jump DB, Busik JV. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 2005;46:4342-4347 (Pubitemid 44264641)
21. Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 2008;57:1952-1965
22. Chen W, Jump DB, Esselman WJ, Busik JV. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007;48:18-26 (Pubitemid 47251381)
23. Agardh E, Gustavsson C, Hagert P, Nilsson M, Agardh CD. Modifying a standard method allows simultaneous extraction of RNA and protein, enabling detection of enzymes in the rat retina with low expressions and protein levels. Metabolism 2006;55:168-174 (Pubitemid 43098983)
24. Macdonald JL, Pike LJ. A simplified method for the preparation of detergent-free lipid rafts. J Lipid Res 2005;46:1061-1067
25. Busik JV, Reid GE, Lydic TA. Global analysis of retina lipids by complementary precursor ion and neutral loss mode tandem mass spectrometry. Methods Mol Biol 2009;579:33-70.
26. Zheng L, Gong B, Hatala DA, Kern TS. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci 2007;48:361-367 (Pubitemid 47251425)
27. Huang WL, King VR, Curran OE, et al. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007;130:3004-3019 (Pubitemid 350033967)
28. Kern TS, Tang J, Mizutani M, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 2000;41:3972-3978
29. Laver NM, Robison WG Jr, Pfeffer BA. Novel procedures for isolating intact retinal vascular beds from diabetic humans and animal models. Invest Ophthalmol Vis Sci 1993;34:2097-2104 (Pubitemid 23148649)
30. Kaneda K, Kashii S, Kurosawa T, et al. Apoptotic DNA fragmentation and upregulation of Bax induced by transient ischemia of the rat retina. Brain Res 1999;815:11-20 (Pubitemid 29225219)
31. Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007;171:53-67 (Pubitemid 47339226)
32. Yang Y, Yin J, Baumgartner W, et al. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase. Eur Respir J 2010;36:417-427
33. Schuchman EH. Acid sphingomyelinase, cell membranes and human disease: Lessons from Niemann-Pick disease. FEBS Lett 2010;584:1895-1900
34. Grassmé H, Jendrossek V, Riehle A, et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 2003;9:322-330 (Pubitemid 36362788)
35. Gulbins E, Grassmé H. Ceramide and cell death receptor clustering. Biochim Biophys Acta 2002;1585:139-145
36. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001;7:186-191 (Pubitemid 32148485)
37. Matthews AN, Friend DS, Zimmermann N, et al. Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA 1998;95:6273-6278 (Pubitemid 28249002)
38. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83(Suppl.):1505S-1519S
39. Tikhonenko M, Lydic TA, Wang Y, et al. Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes 2010;59:219-227
40. Kern TS. In vivo models of diabetic retinopathy. In Diabetic Retinopathy. Duh E, Ed. Totowa, NJ, Humana Press, 2008, p. 137-159
41. Kolesnick RN, Goñi FM, Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J Cell Physiol 2000;184:285-300 (Pubitemid 30625491)
42. Grassmé H, Riethmüller J, Gulbins E. Biological aspects of ceramide-enriched membrane domains. Prog Lipid Res 2007;46:161-170 (Pubitemid 46962121)
43. Opreanu M, Lydic TA, Reid GE, McSorley KM, Esselman WJ, Busik J. Docosahexaenoic acid inhibits cytokine signaling in human retinal endothelial cells by downregulating sphingomyelinases. Invest Ophthalmol Vis Sci 2010;51:3253-3263
44. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010;142:687-698
45. Dumitru CA, Zhang Y, Li X, Gulbins E. Ceramide: a novel player in reactive oxygen species-induced signaling? Antioxid Redox Signal 2007;9:1535-1540
46. Górska M, Barańczuk E, Dobrzyń A. Secretory Zn2+-dependent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated. Horm Metab Res 2003;35:506-507 (Pubitemid 37204569)
47. Patschan S, Chen J, Polotskaia A, et al. Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells. Am J Physiol Heart Circ Physiol 2008;294:H1119-H1129 (Pubitemid 351468704)
48. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 2006;55:2579-2587 (Pubitemid 44871159)
49. Zeidan YH, Wu BX, Jenkins RW, Obeid LM, Hannun YA. A novel role for protein kinase Cdelta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. FASEB J 2008;22:183-193
50. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007;2:366-373